Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccine Immunogenicity in Special Risk Groups
NCT00964210Phase 3Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of qHPV vaccine in human papillomavirus infection, Cervical Cancer (CC), anogenital warts, sponsored by Murdoch Children's Research Institute. Started Mar 2008; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)anogenital warts
Beyond the preview
Go deeper on NCT00964210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964210.